Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. - Wikidata - awgldk - TriplyDB

Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

http://www.wikidata.org/entity/Q34306742

about

Autologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysis Bone marrow derived stem cells for the treatment of end-stage liver disease Autologous bone marrow-derived cells in the treatment of liver disease patients Systematic review: the effects of autologous stem cell therapy for patients with liver disease Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?Ameliorative effect of bone marrow-derived stem cells on injured liver of mice infected with Schistosoma mansoni Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease Liver bioengineering: current status and future perspectives The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol.Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study Management of Liver Failure: From Transplantation to Cell-Based Therapy.Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells on Experimental Liver Injury Induced by Schistosoma mansoni: A Histological Study Stem cells in liver regeneration and their potential clinical applications.Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.Immunological basis of stem cell therapy in liver diseases.Cell therapy for liver diseases: current medicine and future promises.Use of stem cells for liver diseases-current scenario.Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.Could Stem Cell Therapy be the Cure in Liver Cirrhosis?Cell transplantation as a non-invasive strategy for treating liver fibrosis.Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics.Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.Progress in stem cell-based therapy for liver disease.CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure.Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases.Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option.MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.Cell-based liver therapies: past, present and future Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study

P2860

Q26801163-D62BA920-F921-487A-ABB5-52BCC05C4C04 Q26850412-8A73E29A-77CC-445B-A2F7-E26B0D915C55 Q26863284-E8CFC2A2-6EB6-49C1-8DBC-B29943D7BEBE Q27024968-265FF950-E72B-4741-946A-6C8630869103 Q33576787-F140414E-E786-4A08-8B50-DFAEFF7EF92D Q33639255-27602E62-F692-4047-9D24-C0F4B6208846 Q33818431-8C631071-5D72-4483-9713-7BF50FF93CBD Q33900601-DBA0C3E1-55E2-45B0-A8A7-6CBF013E79AD Q34322889-CD5DEA52-FCAE-4F67-9F98-E204D8A7B3B2 Q35786513-C2EAC2F1-C9C5-415B-B89C-E8965C58B812 Q36052362-A9925F5D-98EF-4809-89BB-8D27920E89EC Q36382751-97CFDE3E-E49A-4C2F-93F7-C970BC3A92E6 Q36633041-7A7B5B63-2ABB-4ACE-8A4E-7173A971F0C4 Q36680588-AE69BE51-9ADB-4405-B17F-A67C32DA41D4 Q37126566-D4F615F8-A051-42DA-9370-9A3E463F24F3 Q38092746-160D5693-6541-4CAA-8B82-11CA3FED6C74 Q38159684-78E34D31-86D2-483E-A628-BFE526789F37 Q38223210-0B7046AC-5DD5-4C86-8418-A43B83958F19 Q38369581-A06538E8-6403-486A-96EC-7E8A03CA7F57 Q38371445-7106C5DC-1F5B-4B13-8612-8CB40FDAA787 Q38414766-B71B428D-CCB3-4E46-A4F2-B93746BEAE80 Q38544019-20F7127E-2873-4B5D-8687-651E769708AD Q38675565-1DBC8CCF-7A23-4456-B3A3-0BD9B5A40E2A Q38772557-369A85A3-5476-45FB-ACF7-4BB7FB26DF1D Q38820953-B6F8A6CE-BC35-4911-97AD-B0D7980620CA Q38836460-09C51F01-6375-4702-8C1A-A9E07F482B8F Q44431676-E9B459C8-FA7C-46EB-9FF3-3F3FB89F588B Q47109230-1225F6A6-E276-4E59-BC50-A88F792B571D Q47839652-7552F70A-E777-417D-9E52-3FD4825769FA Q52568315-FE7A05C2-706A-47DC-BD40-F084C630518B Q54256847-A07CA246-AC45-44BE-8B71-F91695E464DE Q57177119-02DECB64-0957-49D5-888F-AC1D55A10B23 Q58551580-855D1346-4557-47E9-A933-40AA92CC00EF

P2860

Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

http://www.wikidata.org/entity/Q34306742

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@ast

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@en

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@nl

type

label

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@ast

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@en

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@nl

prefLabel

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@ast

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@en

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@nl

P1433

Q34306742-0E432E9C-9A73-4AFE-B730-BEA109B3E6E1

P1476

Q34306742-5C8823A8-EEE8-4F97-B5AB-08A177B0E9FD

P2093

Q34306742-0F6038C2-5CC8-44B6-85E2-4970A172B30D

Q34306742-14256E72-330F-4FC9-85EE-208FD53FB7DD

Q34306742-250DC5D3-8573-4E68-9ABA-CEEDB10AD467

Q34306742-56D61B6C-FC86-476D-AED0-1FBE444BDF1D

Q34306742-58FBB7F1-7FD1-488E-BFC0-E70E6374E953

Q34306742-919186A2-8398-4D1E-B4C8-394B99833C1A

Q34306742-DA547885-1E60-4A31-8494-31550242227B

Q34306742-F3223C9E-D6B3-44C0-BBD0-BDDE6393105E

Q34306742-FC1E141D-C535-4D7C-84F3-4A3D2B2B5C4F

P2860

Q34306742-0B6F081A-A9F6-4296-B759-EC12C217D101

Q34306742-18382BBA-83E2-4496-8B4E-1AAA2876756C

Q34306742-1D2D118A-200C-45F5-B781-A4D0BE322D31

Q34306742-39D44F4E-BF91-47D3-BBBB-06A07A7BE80A

Q34306742-3ACD5C25-4D1A-4FCA-9F9B-8C389C813012

Q34306742-57C2E536-DE37-4ED7-9D6D-DD378391B76F

Q34306742-6C05AF49-1A56-4EA7-9014-062C6BEE38D5

Q34306742-6D102E63-A14D-4A7A-9B04-D8CE0F0D2128

Q34306742-7382793A-1DF9-43E2-98AA-B386A25D20E9

Q34306742-76693258-D062-4248-8FA4-EB324C26551E

P304

Q34306742-C83ABC86-FFCD-4DD5-96BB-2B9C5D250549

P31

Q34306742-E22244E9-E59B-437E-B9F0-7D680A940263

P356

Q34306742-056F9660-EDAD-4FCD-9A07-5665D2A18F9C

P407

Q34306742-8B78BF03-81B0-4F06-8E64-73ED445C72EA

P433

Q34306742-136CB1FF-1D2F-4571-87A2-A6C9C7936479

P478

Q34306742-03EB1143-6215-4F5C-9FCC-14D4E7ED5C39

P577

Q34306742-BBFFAF34-F8EE-4AAD-9704-25F58588939F

P698

Q34306742-F8F91EFB-E389-4C09-9C84-6FB8B4BA8BF8

P932

Q34306742-0C4E76BE-DFDB-497F-B8F1-59CEC3A1AB03

P356

WJG.V16.I42.5297

P1433

World Journal of Gastroenterology

P1476

Autologous CD34+ and CD133+ st ...... with end stage liver disease.

@en

P2093

Abdel-Rahman N Zekri

http://www.w3.org/2001/XMLSchema#string

Abeer A Bahnassy

http://www.w3.org/2001/XMLSchema#string

Eman Medhat

http://www.w3.org/2001/XMLSchema#string

Ghada M Sherif

http://www.w3.org/2001/XMLSchema#string

Ghada Mohamed

http://www.w3.org/2001/XMLSchema#string

Hanan A Halim

http://www.w3.org/2001/XMLSchema#string

Hosny Salama

http://www.w3.org/2001/XMLSchema#string

Ola S Ahmed

http://www.w3.org/2001/XMLSchema#string

Sheren A Al Alim

http://www.w3.org/2001/XMLSchema#string

P2860

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy

Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo

Viable offspring derived from fetal and adult mammalian cells

Hematopoietic potential of stem cells isolated from murine skeletal muscle

Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains

Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?

Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice

Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.

Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation.

Bone marrow as a potential source of hepatic oval cells.

P304

5297-5305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I42.5297

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21072892

http://www.w3.org/2001/XMLSchema#string

P932

2980678

http://www.w3.org/2001/XMLSchema#string